Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide for Delayed Graft Function in Kidney Transplant
NCT05513807Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotinamide in delayed graft function (DGF), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2023; status: completed.
02
Drugs
nicotinamide
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT05513807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05513807.